Rofecoxib and clinically significant gastrointestinal events.
Claire
C
Bombardier
Loren
L
Laine
Richard
R
Day
Christopher J
CJ
Hawkey
Marc C
MC
Hochberg
Thomas J
TJ
Schnitzer
D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects* / Q000494:pharmacology*; D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D041981:Gastrointestinal Tract / Q000187:drug effects*; D006801:Humans; D007783:Lactones / Q000009:adverse effects* / Q000494:pharmacology*; D007880:Legislation, Drug; D013450:Sulfones / Q000009:adverse effects* / Q000494:pharmacology*
D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib